GW Pharmaceuticals PLC (GWPH)

Jim Cramer is bearish on Snap-On, Teekay Shipping, FLIR Systems, and GW Pharmaceuticals.

Jim Cramer says last week's selloff played out just like he predicted, and you haven't missed the sale.

Stocks can be a good gifts for individuals since they can be instrumental in wealth creation and demonstrate the power of compounding.

Here are the activist investor's next potential targets.

Although a cannabis ETF launched in April, investors are still likely to find more value in buying individual stocks in the sector, according to traders.

Jim Cramer takes on LAM Research, Yahoo, Alibaba, Applied Materials, and Momo in the Lightning Round.

This is not just a tech-led rally, says Jim Cramer. Keep an eye on stocks like Boeing, CSX, 3M and Carnival.

Aerie Pharmaceuticals, BioCryst Pharmaceuticals and GW Pharmaceuticals were among the biotech movers in premarket trading on Thursday.

Here are Friday's top research calls, including upgrades for Chemours, Incyte and Toyota, and new coverage of Visteon.

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: SOHO, TM, VEC, WWW Downgrades: BID, FF, GWPH Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

The rallies in the stock market could be indicators of irrational exuberance and are not sustainable because of anemic growth, low unemployment and high valuations in equities.

Here are Friday's top research calls, including an upgrade for Costco and new coverage of McDonald's, GW Pharma and Kinder Morgan.

As more states legalize, your portfolio could smoke the competition.

More Detailed Poster Presentation Scheduled for April 25, 2017 at AAN Annual Meeting

- New Phase 3 Data in Lennox-Gastaut Syndrome Selected for Inclusion in the Emerging Science Program -

This innovative biotech offers investors an intriguing play on the medical marijuana business.

In the first quarter of the year we've seen some high-profile IPOs. But they're not all created equal. Here's what investors should keep an eye out for ... and avoid.

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMRK, AXTA, DFT, GWPH, LBRDK, LBTYA, RPM Downgrades: CIEN, CRNT, IMO, SUNW, TG, TRIB, USCR Initiations: FBIO Read on to get TheStreet Quant Ratings' detailed report:

This economy is finally strong enough that a rate hike is natural and necessary, says Jim Cramer.